Systemic reactions and fatalities associated with allergen immunotherapy
The DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Objective The primary objective of this review is to discuss systemic allergic reactions and risk factors associated with the injection of allergen vaccines.Data sources A review of the literature on anaphylactic reaction, adverse effects, and fatalities associated with allergen immunotherapy (IT) was conducted.Study selection The expert opinion of the author was used to select relevant data.Results Systemic allergic reactions associated with the injection of allergen vaccines usually begin within 20 minutes. However, on occasion, they begin 20 to 30 minutes or longer after an injection. Such reactions can also occur after allergen skin testing. Most reactions associated with skin testing and allergen IT are mild and readily respond to appropriate treatment. However, severe and even fatal reactions have been reported with both skin testing and IT.Conclusions Risk factors for skin testing and allergen IT include: 1) patients, particularly asthmatic patients, suffering with seasonal exacerbation of their symptoms; 2) patients who demonstrate exquisite sensitivity to particular allergen(s); 3) patients on beta-blockers; 4) patients with asthma, especially if their asthma is unstable; 5) patients in whom rush IT is used; and 6) patients in whom high doses of potent standardized allergen vaccines are used. It is essential that strict attention be paid to the risk factors for systemic reactions, and that techniques and management be initiated both before and after skin testing or IT to minimize these risks. Done properly, the risk of skin testing and IT is minimal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Anaphylaxis is a persistent concern with AIT, with incidence of reported systemic reactions as high as 65% following rush protocols.1737,1738”
From International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (2018) · cites this paper as [1738]
Citations
Cites
Allergen immunotherapy: Therapeutic vaccines for allergic diseases A WHO position paper
Bousquet, J., Lockey, R., & Malling, H.-J. (1998) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(98)70271-4 · Cited by 1,581
Self-citationFatalities from immunotherapy (IT) and skin testing (ST)
Lockey, R. F., Benedict, L. M., Turkeltaub, P. C., & Bukantz, S. C. (1987) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(87)80164-1 · Cited by 570
Self-citationSurvey of fatalities from skin testing and immunotherapy 1985–1989
Reid, M. J., Lockey, R. F., Turkeltaub, P. C., & Platts-Mills, T. A. E. (1993) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(93)90030-j · Cited by 380
Self-citationImmunotherapy with a standardized Dermatophagoides pteronyssinus extract
Hejjaoui, A., Dhivert, H., Michel, F. B., & Bousquet, J. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(90)90157-y · Cited by 338
COMMITTEE ON SAFETY OF MEDICINES
SCOWEN, E. (1978) · British Journal of Anaesthesia · doi:10.1093/bja/50.12.1270-a · Cited by 296
Cooke, R. A., & Veer, A. V. (1916) · The Journal of Immunology · doi:10.4049/jimmunol.1.3.201 · Cited by 294
CSM Update: Desensitising vaccines
(1986) · BMJ · doi:10.1136/bmj.293.6552.948 · Cited by 241
VAUGHAN, W. T. (1939) · The American Journal of the Medical Sciences · doi:10.1097/00000441-193912000-00016 · Cited by 234
Immunologic mechanisms in hypersensitivity reactions to metal ions: an overview
Büdinger, L., Hertl, M., & Büdinger, L. (2000) · Allergy · doi:10.1034/j.1398-9995.2000.00107.x · Cited by 218
The Hymenoptera venom study III: Safety of venom immunotherapy
Lockey, R. F., Turkeltaub, P. C., Olive, E. S., Hubbard, J. M., Baird-Warren, I. A., & Bukantz, S. C. (1990) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(05)80182-4 · Cited by 179
Self-citation
Research works printed but not linked: 5
- Hepner, 1987, The safety of immunotherapy: a prospective study, J Allergy Clin Immunol, 79, 133
- Sheppe, 1930, Fatal anaphylaxis in 5man, J Lab Clin Med, 16, 372
- Raphael, 1976, Positive late antiglobulin test in atopic pediatric subjects receiving hyposensitization therapy, J Allergy Clin Immunol, 57, 231
- Petalas, 2000, Systemic allergic reactions to specific immunotherapy. Correlation with: a) symptoms, severity of systemic reactions and b) time of onset, Allergy, 55, 108
- Lüderitz-Püchel, 1996, Incidents following hyposensitization in German, Münch Med Wochenschr, 138, 45
Cited by
Allergen immunotherapy: A practice parameter third update
Cox, L., Nelson, H., Lockey, R., Calabria, C., Chacko, T., Finegold, I., Nelson, M., Weber, R., Bernstein, D. I., Blessing-Moore, J., et al. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.09.034 · Cited by 1,256
“C Patients with severe or uncontrolled asthma are at increased risk for systemic reactions to immunotherapy injections.(142,143,182) Three surveys found that deaths from immunotherapy were more common in patients with asthma that was symptomatic, labile, or both.”
BackgroundSelf-citationThe Journal of Allergy and Clinical Immunology
(1999) · Journal of Allergy and Clinical Immunology · doi:10.1016/s0091-6749(99)70212-5 · Cited by 1,093
The diagnosis and management of anaphylaxis practice parameter: 2010 Update
Lieberman, P., Nicklas, R. A., Oppenheimer, J., Kemp, S. F., Lang, D. M., Bernstein, D. I., Bernstein, J. A., Burks, A. W., Feldweg, A. M., Fink, J. N., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.022 · Cited by 739
EAACI Guidelines on Allergen Immunotherapy: Allergic Rhinoconjunctivitis
Roberts, G., Pfaar, O., Akdis, C. A., Ansotegui, I. J., Durham, S. R., Gerth van Wijk, R., Halken, S., Larenas‐Linnemann, D., Pawankar, R., Pitsios, C., et al. (2018) · Allergy · doi:10.1111/all.13317 · Cited by 702
“Fatal allergic adverse reactions have though been reported in earlier surveys.(30,31) Over 80% of reactions occurred within 30 minutes after injection; very few of the delayed ones were severe.”
BackgroundClinical Practice Guideline: Allergic Rhinitis
Seidman, M. D., Gurgel, R. K., Lin, S. Y., Schwartz, S. R., Baroody, F. M., Bonner, J. R., Dawson, D. E., Dykewicz, M. S., Hackell, J. M., Han, J. K., et al. (2015) · Otolaryngology–Head and Neck Surgery · doi:10.1177/0194599814561600 · Cited by 671
“There have been no fatalities reported as a result of prick inhalant testing and 6 fatalities from intradermal inhalant testing, with 5 of these being asthmatic patients for whom prick testing did not precede intradermal testing.(38,48) There is considerable variation in clinical practice in (1) the number of skin tes…”
Background
Metadata
- Authors
- Lockey, R. F., Nicoara-Kasti, G. L., Theodoropoulos, D. S., & Bukantz, S. C.
- Affiliations
- University of South Florida (US)
- Corresponding author
- Lockey, Richard F.
- ORCID
- Lockey, Richard F.
- Venue
- Annals of Allergy, Asthma & Immunology
- Publisher
- Elsevier BV
- Published
- 2001-07
- Volume
- 87
- Issue
- 1
- Pages
- 47-55
- ISSN
- 1081-1206 (ISSN-L)
- OpenAlex
- W2042692333
- Cited by
- 141
- References
- 72
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 3 · 2023: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 8 · 2018: 4 · 2017: 14 · 2016: 7 · 2015: 8 · 2014: 4 · 2013: 4 · 2012: 5
- FWCI
- 0.70
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Annals of Allergy Asthma & Immunology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Pharmacology (medical) › Drug-Induced Adverse Reactions
- Keywords
- allergen immunotherapy, systemic allergic reactions, anaphylaxis, allergen skin testing, fatal reactions, risk factors, asthma, beta-blockers, rush immunotherapy, adverse effects
- MeSH terms
- Allergens, Humans, Immunotherapy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Systemic reactions and fatalities associated with allergen immunotherapy. https://app.cochat.ai/papers/10.1016/s1081-1206(10)62195-3
- The paper
- Lockey, R. F., Nicoara-Kasti, G. L., Theodoropoulos, D. S., & Bukantz, S. C. (2001). Systemic reactions and fatalities associated with allergen immunotherapy. Annals of Allergy, Asthma & Immunology. https://doi.org/10.1016/s1081-1206(10)62195-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.